RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+20.34%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.16B
AUM Growth
+$4.16B
(+7.4%)
Cap. Flow
+$89.8M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
34.47%
Holding
128
New
1
Increased
41
Reduced
25
Closed
8
Top Buys
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$42.5M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$30.5M |
| 3 |
Baxter International
BAX
|
$20.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$16.5M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$15.5M |
Top Sells
| 1 |
CVET
Covetrus, Inc. Common Stock
CVET
|
$35.1M |
| 2 |
Talphera
TLPH
|
$13.6M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$13.4M |
| 4 |
Arvinas
ARVN
|
$12.5M |
| 5 |
OHPAU
Orion Acquisition Corp. Unit
OHPAU
|
$9.87M |
Sector Composition
| 1 | Healthcare | 97.81% |
| 2 | Consumer Staples | 0.83% |
| 3 | Industrials | 0.36% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mersana Therapeutics
MRSN
$36.5M
| $24M | 0.58% | 4,103,803 +27,845 | +0.7% | +$163K |
|
|
SWAV
52
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $23.7M | 0.57% | 115,100 -65,000 | -36% | -$13.4M |
|
53
Legend Biotech
LEGN
$6.41B
| $22.5M | 0.54% | 450,466 | – | – |
|
54
BioCryst Pharmaceuticals
BCRX
$1.74B
| $21.7M | 0.52% | 1,890,737 +178,230 | +10% | +$2.05M |
|
55
Azenta
AZTA
$1.4B
| $20.5M | 0.49% | 351,500 +21,300 | +6% | +$1.24M |
|
56
Cytokinetics
CYTK
$4.23B
| $20.3M | 0.49% | 443,000 | – | – |
|
57
Travere Therapeutics
TVTX
$1.56B
| $20M | 0.48% | 951,650 | – | – |
|
58
Immatics
IMTX
$619M
| $19.8M | 0.48% | 2,274,784 +593,560 | +35% | +$5.17M |
|
59
Dynavax Technologies
DVAX
$1.19B
| $19.3M | 0.46% | 1,813,758 +130,400 | +8% | +$1.39M |
|
60
Celldex Therapeutics
CLDX
$1.47B
| $18.8M | 0.45% | 421,504 -100 | -0% | -$4.46K |
|
61
CONMED
CNMD
$1.68B
| $18.2M | 0.44% | 205,000 -28,000 | -12% | -$2.48M |
|
62
AnaptysBio
ANAB
$569M
| $17.9M | 0.43% | 576,600 | – | – |
|
63
Collegium Pharmaceutical
COLL
$1.22B
| $16.8M | 0.4% | 725,000 | – | – |
|
64
Warby Parker
WRBY
$3.2B
| $16.4M | 0.4% | 1,218,975 -90,500 | -7% | -$1.22M |
|
|
ACCD
65
DELISTED
Accolade, Inc. Common Stock
ACCD
| $15.1M | 0.36% | 1,938,000 -336,000 | -15% | -$2.62M |
|
|
CINC
66
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $13.7M | 0.33% | 1,116,578 -89,278 | -7% | -$1.1M |
|
67
Lifestance Health
LFST
$2.13B
| $13.3M | 0.32% | 2,700,000 +700,000 | +35% | +$3.46M |
|
|
KDNY
68
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $13.3M | 0.32% | 507,512 | – | – |
|
69
Amicus Therapeutics
FOLD
$2.34B
| $13M | 0.31% | 1,063,806 +51,300 | +5% | +$626K |
|
|
VERV
70
DELISTED
Verve Therapeutics
VERV
| $10.8M | 0.26% | 558,837 | – | – |
|
71
Aura Biosciences
AURA
$389M
| $10.7M | 0.26% | 1,019,757 +4,000 | +0.4% | +$42K |
|
72
Relay Therapeutics
RLAY
$619M
| $10.1M | 0.24% | 673,966 +55,699 | +9% | +$832K |
|
73
Health Catalyst
HCAT
$239M
| $9.88M | 0.24% | 929,900 +49,900 | +6% | +$530K |
|
|
EDAP
74
EDAP TMS
EDAP
$84.5M
| $9.7M | 0.23% | 910,000 | – | – |
|
|
AMYT
75
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $9.68M | 0.23% | 1,325,625 | – | – |
|